Johnson & Johnson (JNJ)
254.66
+9.78 (3.99%)
NYSE· Last Trade: Jun 26th, 6:52 PM EDT
Detailed Quote
| Previous Close | 244.88 |
|---|---|
| Open | 248.27 |
| Bid | 254.05 |
| Ask | 254.66 |
| Day's Range | 247.87 - 255.11 |
| 52 Week Range | 150.73 - 251.71 |
| Volume | 16,314,915 |
| Market Cap | 669.42B |
| PE Ratio (TTM) | - |
| EPS (TTM) | - |
| Dividend & Yield | 5.360 (2.10%) |
| 1 Month Average Volume | 8,645,059 |
Chart
About Johnson & Johnson (JNJ)
Johnson & Johnson is a multinational corporation engaged in the development, manufacturing, and marketing of a wide range of healthcare products. The company operates through three primary segments: pharmaceuticals, medical devices, and consumer health products. Johnson & Johnson is known for its commitment to innovation in healthcare, producing a diverse array of products that include prescription medications for various diseases, sophisticated medical devices for surgical procedures, and widely recognized consumer brands for personal care and wellness. With a focus on improving health outcomes, the company aims to address the evolving needs of patients and consumers around the world. Read More
News & Press Releases
Uncover the latest developments among dow jones stocks in today's session.chartmill.com
Via Chartmill · June 26, 2026
Johnson & Johnson stock makes good drugs, but it's valuation isn't great.
Via The Motley Fool · June 26, 2026
Bristol Myers Squibb leans on specialty medicines and a discounted valuation, while Johnson & Johnson boasts industry-leading margins and cash flow.
Via The Motley Fool · June 26, 2026
Explore the top gainers and losers within the dow jones index in today's session.chartmill.com
Via Chartmill · June 26, 2026
Johnson & Johnson is a healthcare giant, but an opportunity to invest in the United States and a plethora of big products suggest it still has growth appeal.
Via The Motley Fool · June 26, 2026
Stay informed with the top movers within the dow jones index on Thursday.chartmill.com
Via Chartmill · June 25, 2026
What's going on in today's session: dow jones moverschartmill.com
Via Chartmill · June 25, 2026
Their dividends are about as safe as they come.
Via The Motley Fool · June 25, 2026
Low-risk stocks are back in vogue.
Via The Motley Fool · June 23, 2026
Uncover the latest developments among dow jones stocks in today's session.chartmill.com
Via Chartmill · June 23, 2026
Exploring the top movers within the dow jones index during today's session.chartmill.com
Via Chartmill · June 23, 2026
Long-term investors should skip the SpaceX roller coaster, and pivot toward these three Dividend Kings instead.
Via The Motley Fool · June 22, 2026
Which dow jones stocks are moving on Monday?chartmill.com
Via Chartmill · June 22, 2026
Top dow jones movers in Monday's sessionchartmill.com
Via Chartmill · June 22, 2026
Get rich slowly. How? Hold these stocks and reinvest the dividends they pay.
Via The Motley Fool · June 22, 2026
Young adults with median earnings can build sizable portfolios that pay a hefty amount of passive income by retirement.
Via The Motley Fool · June 22, 2026
These well-established companies are on track to deliver more growth.
Via The Motley Fool · June 20, 2026
In an unstable market, these three companies offer investors a chance to own durable consumer businesses that generate steady growth regardless of economic headlines.
Via The Motley Fool · June 20, 2026
Bear markets are a part of investing life, but you can prepare for them ahead of time.
Via The Motley Fool · June 19, 2026
Stay informed with the top movers within the dow jones index on Thursday.chartmill.com
Via Chartmill · June 18, 2026
Uncover the latest developments among dow jones stocks in today's session.chartmill.com
Via Chartmill · June 18, 2026
Led by Eli Lilly’s GLP-1 success, Humana’s expanding margins, and DexCom’s medtech growth, the healthcare sector is staging a major market rebound.
Via MarketBeat · June 18, 2026
Explore the top gainers and losers within the dow jones index in today's session.chartmill.com
Via Chartmill · June 17, 2026
It could be a great move by the billionaire hedge fund manager.
Via The Motley Fool · June 16, 2026